US 9220772
Anti-tumor antigen antibodies and methods of use
granted A61KA61K39/39558A61K47/60
Quick answer
US patent 9220772 (Anti-tumor antigen antibodies and methods of use) held by The Regents of the University of California expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K39/39558, A61K47/60, A61P, A61P35/00